Evidence map›Paper›PMID 38002071›Full record

ArticleBiomedicines2023

Development of 2'-O-Methyl and LNA Antisense Oligonucleotides for

Marianna Maretina, Arina Il'ina, Anna Egorova, Andrey Glotov, Anton Kiselev

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marianna MaretinaDepartment of Genomic Medicine Named after V.S. Baranov, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 199034 Saint Petersburg, Russia.
Arina Il'inaFaculty of Biology, Saint Petersburg State University, Universitetskaya Embankment 7-9, 199034 Saint Petersburg, Russia.
Anna EgorovaDepartment of Genomic Medicine Named after V.S. Baranov, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 199034 Saint Petersburg, Russia.
Andrey GlotovDepartment of Genomic Medicine Named after V.S. Baranov, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 199034 Saint Petersburg, Russia.ORCID 0000-0002-7465-4504
Anton KiselevDepartment of Genomic Medicine Named after V.S. Baranov, D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Mendeleevskaya Line 3, 199034 Saint Petersburg, Russia.ORCID 0000-0002-2487-2423
Research Institute of Obstetrics and Gynecology named after D.O. Ott · RUSt Petersburg University · RU

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2021-1058
6 · The paper itself

Abstract

Spinal muscular atrophy (SMA) is a devastating neurodegenerative disease caused by mutations in the

Indexed as

2′-O-methyl modificationantisense oligonucleotidesLNAnuclear gemsSMN1 geneSMN2 genespinal muscular atrophysplicing correction

Identifiers

PMID38002071
PMCPMC10669464
OpenAlexW4388731284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.